Acute Myelocytic Leukemia

Common Name(s)

Acute Myelocytic Leukemia, AML - Acute myeloid leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Acute Myelocytic Leukemia" for support, advocacy or research.

4th Angel Mentoring Program

Learning that you have cancer can be an overwhelming experience – one that leaves you frightened, vulnerable and alone. The 4th Angel Mentoring Program offers free, one-on-one, confidential outreach and support from someone who has successfully made the same journey you are about to begin – the journey towards recovery. This specially trained volunteer and cancer survivor – your 4th Angel – is someone who will talk and listen in a supportive setting. The 4th Angel Mentoring Program is telephone based, so you can be connect with an angel anywhere in the country. 4th Angel Mentoring Program is part of The Scott Hamilton CARES Initiative, a national non-profit organizat

Last Updated: 12 Dec 2012

View Details
Logo
MPDSUPPORT.ORG

Since 1994, our MPD-SUPPORT web site and free support email list offers interesting information on chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, myelodysplasia, and myelofibrosis. Anyone - patient, family member, or health professional, is welcome to join our growing list of subscribers. Our archives are available for you to research information.

Last Updated: 14 Jan 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Acute Myelocytic Leukemia" for support, advocacy or research.

4th Angel Mentoring Program

Learning that you have cancer can be an overwhelming experience – one that leaves you frightened, vulnerable and alone. The 4th Angel Mentoring Program offers free, one-on-one, confidential outreach and support from someone who has successfully made the same journey you are about to begin – the journey towards recovery. This specially trained volunteer and cancer survivor – your 4th Angel – is someone who will talk and listen in a supportive setting. The 4th Angel Mentoring Program is telephone based, so you can be connect with an angel anywhere in the country. 4th Angel Mentoring Program is part of The Scott Hamilton CARES Initiative, a national non-profit organizat

http://www.4thangel.org

Last Updated: 12 Dec 2012

View Details
Logo
MPDSUPPORT.ORG

Since 1994, our MPD-SUPPORT web site and free support email list offers interesting information on chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, myelodysplasia, and myelofibrosis. Anyone - patient, family member, or health professional, is welcome to join our growing list of subscribers. Our archives are available for you to research information.

http://www.mpdsupport.org

Last Updated: 14 Jan 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Acute Myelocytic Leukemia" returned 45 free, full-text research articles on human participants. First 3 results:

Refractory hemophagocytic syndrome in a patient with acute myelocytic leukemia.
 

Author(s): Toru Takahashi, Masafumi Matsugama

Journal: Blood. 2013 Apr;121(15):2820.

 

Last Updated: 23 May 2013

Go To URL
Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission.
 

Author(s): Norbert-Claude Gorin, Myriam Labopin, Giovanna Meloni, Arnaud Pigneux, Jordi Esteve, Mohty Mohamad,

Journal: Haematologica. 2013 Feb;98(2):e12-4.

 

Last Updated: 1 Feb 2013

Go To URL
Relation between IRF-1 gene and acute myelocytic leukemia in Kashmiri population.
 

Author(s): Tanzeela Khan, Bashir Ahmad Ganai, Akbar Masood, Jeelani Samoon, Sabha Rasool Beigh, Falak Qazi

Journal: Asian Pac. J. Cancer Prev.. 2011 ;12(4):1035-9.

 

The IRF-1 protein, a mammalian transcriptional factor encoded by a gene located in 5q23-q31, has antioncogenic properties. Involved in regulation of differentiation and proliferation, IRF-1 acts as a tumor suppressor gene and is inactivated by deletion of its one or more exons (exon ...

Last Updated: 27 Jul 2011

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Acute Myelocytic Leukemia" returned 3 free, full-text review articles on human participants. First 3 results:

[Importance of immunophenotyping of leukemia myelocytic acute].
 

Author(s): S L Martins, R P Falcão

Journal: Rev Assoc Med Bras. ;46(1):57-62.

 

Last Updated: 14 Aug 2000

Go To URL
Autologous stem cell transplantation in acute myelocytic leukemia.
 

Author(s): N C Gorin

Journal: Blood. 1998 Aug;92(4):1073-90.

 

Last Updated: 10 Sep 1998

Go To URL
Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
 

Author(s): A C Martens, D W van Bekkum, A Hagenbeek

Journal: Int. J. Cell Cloning. 1990 Jan;8(1):27-38.

 

The possibilities for studying minimal residual disease (MRD) in human acute myelocytic leukemia (AML) are limited. Animal models are, therefore, indispensable for gaining insight into the characteristics of leukemia growth during the MRD phase. Studies were done to compare AML to ...

Last Updated: 30 Jan 1990

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Lenalidomide in Combination With HLA-mismatched Stem-cell Microtransplantation as Post-remission Therapy in Acute Myeloid Leukemia
 

Status: Not yet recruiting

Condition Summary: Acute Myeloid Leukemia (AML); Acute Myelocytic Leukemia; Acute Myelogenous Leukemia; Acute Granulocytic Leukemia; Acute Non-Lymphocytic Leukemia

 

Last Updated: 29 Sep 2014

Go to URL
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
 

Status: Recruiting

Condition Summary: Antineoplastic Adverse Reaction; Thrombocytopenia; Acute Myelocytic Leukemia

 

Last Updated: 18 Sep 2014

Go to URL
A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)
 

Status: Recruiting

Condition Summary: Acute Myelogenous Leukemia; AML; Acute Myeloid Leukemia

 

Last Updated: 29 Oct 2014

Go to URL